ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1391	National Cancer Institute	Html	en	Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of Wilms tumor.	wilms tumors 0.503727 wilms tumor 0.905843 Wilms tumor development 0.5254 Wilms tumor genetics 0.517912 Wilms Tumor Study-5 0.477443 familial Wilms tumour 0.446601 favorable-histology wilms tumor 0.511105 stage II Wilms 0.439212 unilateral Wilms tumor 0.553115 Wilms tumor patients 0.529584 favorable histology Wilms 0.460427 bilateral Wilms patients 0.460054 Tumor Study Group 0.595101 contralateral Wilms tumor 0.495745 Wilms tumor-Aniridia syndrome 0.439108 preoperative wilms tumor 0.505524 bilateral wilms tumor 0.635902 stromal-type Wilms tumor 0.516983 Wilms tumor surveillance 0.49553 beckwith-wiedemann syndrome 0.43423 inoperable Wilms tumor 0.526248 Group/National Wilms Tumor 0.47873 Low-risk Wilms Tumor 0.474612 histology Wilms tumors 0.433526 Wilms Tumor Study 0.723902	Wilms tumor screening 0.479856 wilms tumor rupture 0.501052 et al. 0.499553 wilms tumor predisposition 0.521351 histology Wilms tumor 0.504567 Wilms tumours 0.453209 COG Wilms tumor 0.518219 SIOP Wilms Tumor 0.504401 Wilms tumour 0.50015 bilateral Wilms tumor. 0.45063 Pediatr Blood Cancer 0.440629 wilms tumor suppressor 0.492641 nonsyndromic Wilms tumor 0.493832 Metachronous bilateral Wilms 0.434751 National Wilms Tumor 0.736085 Med Genet 0.447601 Abstract 0.531043 Clin Oncol 0.453706 familial Wilms tumor. 0.444435 Wilms tumor locus 0.521817 Familial Wilms tumor 0.495658 non-WT1-syndromic Wilms tumor 0.488494 Wilms Tumor Study-3 0.478135 Wilms tumor susceptibility 0.497583	CLICK HERE
1528	National Cancer Institute	Html	en	Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.	currently used treatment 0.491433 treatment 0.80031 abnormal cells 0.591776 cancer treatment 0.491469 ovaries 0.553108 abdomen 0.566902 body cavity 0.495458 NCI-supported cancer 0.497228 tissue 0.516419 cancer cells 0.493195 body 0.515176 Cancer Information Service 0.489344 low malignant potential 0.507879 PDQ cancer information 0.620272 clinical trial search 0.566415 uterus 0.498028 treatment clinical trials 0.555055 National Cancer Institute 0.572253 clinical trials 0.964888 tumor cells 0.695966 Treatment Options section 0.484079 cancer information summary 0.567078 clinical trial 0.741404 new treatment 0.564234	disease 0.554973 malignant potential tumor 0.900634 new treatments 0.489278 patients 0.603036 earlier clinical trials 0.497766 clinical trials database 0.496798 peritoneal cavity 0.517264 Potential Tumors Treatment 0.491558 treatment clinical trial 0.511947 PDQ Adult Treatment 0.504736 NCI PDQ cancer 0.507801 ovary 0.536161 cancer clinical trials 0.578107 tests 0.498811 stage 0.7416 malignant potential tumors 0.621847 fallopian tubes 0.57444 treatment options 0.549139 Treatment Editorial Board 0.533517 cancer information summaries 0.487894 comprehensive cancer information 0.488381 cancer 0.721628 standard treatment 0.552748	CLICK HERE
1712	National Cancer Institute	Html	en	Antioxidants and Cancer Prevention	A fact sheet about antioxidants, substances that may protect cells from the damage caused by unstable molecules known as free radicals. Free radical damage may lead to cancer.	Nutrition Intervention Trial 0.501895 esophageal cancer 0.494202 cancer prevention 0.637226 dietary antioxidant supplements 0.628093 Retinol Efficacy Trial 0.539912 antioxidants 0.567107 supplementation 0.636543 beta-carotene supplementation 0.609246 vitamin E supplementation 0.519408 randomized controlled trials 0.504401 trial 0.573618 daily supplementation 0.567334 lung cancer 0.591669 Alpha-Tocopherol/Beta-Carotene Cancer Prevention 0.499391 Health Study 0.544001 free radical damage 0.506138 beta-carotene supplements 0.507967 National Cancer Institute 0.710208 dietary antioxidants 0.513132 beta carotene 0.496454 cardiovascular disease 0.651531 Cancer Prevention Study 0.537001 Vitamin E Cancer 0.510878	free radicals 0.842716 exogenous antioxidants 0.527581 Cancer Prevention Trial 0.559457 alpha-tocopherol supplementation 0.518828 gastric cancer 0.506898 skin cancer incidence 0.521176 antioxidant vitamins 0.499147 cancer development 0.495835 total cancer incidence 0.520828 randomized controlled trial 0.509347 antioxidant supplementation 0.554893 antioxidant supplements 0.754474 prostate cancer 0.575846 effects 0.540142 all-cause mortality 0.510888 et al 0.922404 New England Journal 0.537799 cancer risk 0.507337 lung cancer incidence 0.528817 cancer 0.94983 incidence 0.572134 cancer incidence 0.567041 long-term beta-carotene supplementation 0.539474	CLICK HERE
2041	National Cancer Institute	Html	es	Exámenes de detección del cáncer de vejiga y otros cánceres uroteliales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las pruebas que se usan para detectar sistemáticamente el cáncer de vejiga.	antecedentes familiares 0.40081 Schistosoma haematobium 0.417111 Visuals Online 0.357081 PDQ Exámenes 0.503031 Physician Data Query 0.696072 Estados Unidos 0.406708 túbulos renales 0.432914 prevención revisa 0.368302 sistema urinario masculino 0.518469	largo plazo 0.406946 vejiga almacena 0.840919 información ayuda 0.374743 biopsia.ampliar cistoscopia 0.431465 National Cancer Institute 0.400139 siguientes riesgos 0.364163 pelvis renal 0.934476 Instituto Nacional 0.483729	CLICK HERE
2076	National Cancer Institute	Html	es	Alcohol y el riesgo de cáncer	Hoja informativa que resume la comprobación de la relación entre el consumo de alcohol y el riesgo de varios cánceres. Incluye información de los factores que afectan el riesgo de cánceres asociados con el alcohol, como son los genes y el uso de tabaco.	Neck Cancer Epidemiology 0.538614 Lancet Oncology 0.534891 Hirose K 0.511352 Matsuo K 0.510531 levadura fermenta azúcares 0.523222 pharyngeal cancers 0.510877 Alcohol drinking cessation 0.626157 British Journal 0.511017 vitamina a 0.51094 Straif K 0.510855 vitamina e 0.511443 IARC Monographs 0.512402 IARC Working Group 0.518509 riesgos resultantes 0.517271 Estados Unidos 0.591854 alcohol drinking 0.759868 Tajima K 0.511125 PubMed Abstract 0.957874 neck cancers 0.610459 Cancer Epidemiology 0.551257 Beral V 0.510723 Liver Disease 0.511887 cancer prevention 0.54975 alcohol consumption with 0.621668 vino tinto 0.531211	results from subgroup 0.518268 International Head 0.510721 Fedirko V 0.510662 contaminantes cancerígenos 0.510849 Carcinogenic Risks 0.530612 ADH hiperactiva 0.535244 Numerosos estudios 0.516257 preclinical studies 0.511192 enzima hiperactiva 0.522144 Bonifazi M 0.510536 epidemiological studies 0.512501 Hodgkin lymphoma 0.511109 enzima adh hiperactiva 0.532963 Tramacere I 0.552596 genetic polymorphisms 0.530043 enzima llamada 0.519065 Bagnardi V 0.51066 Rehm J 0.529488 cabo estudios 0.515059 pooled analysis 0.527827 renal cell carcinoma 0.521274 Cancer Institute 0.525901 células renales 0.53114 New York Academy 0.514614	CLICK HERE
3527	National Cancer Institute	Html	es	Cáncer de próstata, nutrición y suplementos alimentarios (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de la nutrición y los suplementos alimentarios para disminuir el riesgo de presentar cáncer de próstata o como tratamiento del mismo.	World Cancer Research 0.326698 Cancer Research Fund 0.313691 Causes Control 0.305123 Sin embargo 0.321932 accessed october 0.306323 productos lácteos 0.431605 vitamina d 0.31442 ayunas polyphenon 0.305303 Preventive Services Task 0.311029 vitamina e 0.30874 Instituto Nacional 0.305332 GEGC Estado Duración 0.307099 ratones tramp 0.382139 among men with 0.325726 Estados Unidos 0.340412 Natl Cancer Inst 0.313037 Ayunas Dosis 0.305586 PDQ Prevención 0.307 men with 0.346832 systematic evidence review 0.313097 prostate tumor 0.309841 cohort studies 0.305885 Cancer Prostate Sweden 0.316805 cohort study 0.307709 Boon H 0.305432	vitamin d 0.306351 dietary calcium 0.324651 diagnosed with 0.308047 Prostate CAncer Therapy 0.319442 Nutr Cancer 0.324876 as risk factors 0.306238 alto consumo 0.312193 Cancer Research 0.341162 Cancer Care 0.312902 Epidemiol Biomarkers Prev 0.355426 Mitrou PN 0.306395 Clin Nutr 0.308257 subsequent risk 0.305051 estudio pcats 0.30523 Services Task Force 0.310689 principales fuentes 0.3052 systematic review 0.306566 risk factor 0.3097 Dietary calcium does 0.306286 prostate cancer 0.981425 Albanes D 0.30581 Polyphenon E 0.333052 risk with specific 0.307113 dairy products 0.430021	CLICK HERE
14599	National Cancer Institute	Html	en	PET-CT–Guided Surveillance May Reduce Need for Surgery in Some Patients with Advanced Head and Neck Cancer	Patients with advanced squamous cell carcinoma of the head and neck who underwent PET-CT–guided surveillance had fewer operations but similar overall survival rates to those of patients who underwent planned neck dissection.	fewer neck dissections 0.480753 different PET-imaging systems 0.416156 trial 0.383529 surgical dissection 0.49691 surgery group 0.546725 equivocal response 0.373027 main goal 0.370069 standard first-line therapy 0.446339 2-year overall survival 0.421723 results 0.372041 PET-CT–guided surveillance 0.384586 PET-CT group 0.386097 advanced squamous cell 0.578344 standardized PET imaging 0.419169 heterogeneous study population 0.413368 2,200-per-patient cost savings 0.413451 study groups 0.42202 patients 0.610711 metabolic abnormalities 0.37096 Dr. Malik 0.419332 health care costs 0.414997 lymph nodes 0.375275 overall survival rates 0.55552 surveillance group 0.491325	chemoradiation 0.396529 Shakun Malik 0.372291 nodal metastases 0.375714 positron-emission tomography 0.373068 magnetic resonance imaging 0.431542 Cancer Research UK 0.422638 Technology Assessment Programme 0.42519 United States 0.41309 N3 disease 0.374897 fewer operations 0.382441 randomized controlled PET-NECK 0.429823 PET-CT imaging 0.485125 advanced imaging techniques 0.434786 neck dissection 0.819668 PET-CT surveillance 0.497223 neck dissection patients 0.544115 Hisham Mehanna 0.370962 long-term results 0.369928 trial results 0.371832 United Kingdom 0.369679 cancer treatment centers 0.428263 substantial complications 0.369604 New England Journal 0.442645 clinical usefulness 0.371858	CLICK HERE
17277	National Cancer Institute	Html	null	Cáncer avanzado y quienes cuidan	Si usted cuida a un paciente, puede sentir cansancio y preocupación a medida que se enfrenta al cáncer de su ser querido. Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas.			CLICK HERE
17288	National Cancer Institute	Html	es	Personal de atención para la salud	Información sobre el equipo de tratamiento de proveedores de salud que trabajan juntos para ayudar a pacientes con cáncer.	cuáles alimentos 0.989407		CLICK HERE
17292	National Cancer Institute	Html	es	Sangrado y moretones (trombocitopenia)	Información y consejos para controlar el sangrado y los moretones, los cuales son efectos secundarios del tratamiento del cáncer.	lip balm 0.762223		CLICK HERE